Colombia Rafael Salamanca, the founder of Depósito de Drogas Boyacá, shares his insights on the recent developments of the company in the challenging Colombian logistics environment, while revealing the essence of the company’s success relying on the combination of key factors: product, amount, customer, place and time. You’ve been in the…
Greece From Greece to the world – Rafarm is an example of a local champion in the midst of realizing its global ambitions. Blessed with the duality of a family-run business philosophy and extroverted internationalization strategies, Rafarm’s Vice President, Aris Mitsopoulos, proudly speaks about the company’s impressive growth, its diverse business…
London Among the assorted pharma CEOs and KOLs gathered at the recent Financial Times Pharmaceutical and Biotechnology Conference in London, debate raged on the pros and cons of a pure play strategy, focusing on a few key therapeutic areas, compared to a more diversified approach. If the 1990s and early 2000s, were all…
Pharma The Head of Corporate & Institutional Banking of the Mauritius Commercial Bank explains why the diversification of the Mauritian economy into the healthcare and life sciences sector is necessary and why it will be successful. Furthermore, he specifies the factors that make Mauritius one of the best FDI (Foreign Direct…
biotech Portuguese pharmaceutical group Bluepharma consists of ten companies that represent different parts of the medicine value chain. The success of Bluepharma during Portugal’s crisis was due to a strong focus on overseas exports and diversification of risk. Paulo Barradas and Sérgio Simões explain how they created that success. Bluepharma…
See our Cookie Privacy Policy Here
